MARCOS GONZÁLEZ DÍAZ-rekin lankidetzan egindako argitalpenak (9)

2015

  1. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations

    BioMed Research International, Vol. 2014

2012

  1. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling

    Annals of Oncology, Vol. 23, Núm. 8, pp. 2138-2146

2009

  1. Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas

    Cancer, Vol. 115, Núm. 16, pp. 3728-3737

  2. Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation

    Clinical and Experimental Dermatology, Vol. 34, Núm. 8

2005

  1. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia

    Leukemia, Vol. 19, Núm. 3, pp. 402-409

2001

  1. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization

    Leukemia, Vol. 15, Núm. 5, pp. 840-845

2000

  1. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: Monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells

    Haematologica, Vol. 85, Núm. 11, pp. 1146-1152

1995

  1. Clinical, biological, and immunophenotypical characteristics of B‐cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization

    Cytometry, Vol. 22, Núm. 3, pp. 217-222